Stocks and Investing
Stocks and Investing
Fri, May 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $20 on, May 12th, 2023
Joseph Pantginis of HC Wainwright & Co., Reiterated "Astria Therapeutics, Inc." (ATXS) at Strong Buy and Held Target at $20 on, May 12th, 2023.
Joseph has made no other calls on ATXS in the last 4 months.
There is 1 other peer that has a rating on ATXS. Out of the 1 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $18 on, Tuesday, March 28th, 2023
Contributing Sources